1. Home
  2. LNTH vs STVN Comparison

LNTH vs STVN Comparison

Compare LNTH & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

N/A

Current Price

$76.81

Market Cap

4.9B

Sector

Health Care

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

N/A

Current Price

$15.36

Market Cap

4.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
LNTH
STVN
Founded
1956
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.2B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
LNTH
STVN
Price
$76.81
$15.36
Analyst Decision
Buy
Buy
Analyst Count
6
4
Target Price
$83.20
$25.13
AVG Volume (30 Days)
875.1K
636.8K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
0.41%
EPS Growth
N/A
N/A
EPS
3.41
N/A
Revenue
$343,374,000.00
N/A
Revenue This Year
N/A
$10.26
Revenue Next Year
$13.47
$10.02
P/E Ratio
$21.33
$27.15
Revenue Growth
3.62
N/A
52 Week Low
$47.27
$13.91
52 Week High
$111.29
$28.00

Technical Indicators

Market Signals
Indicator
LNTH
STVN
Relative Strength Index (RSI) 62.60 43.93
Support Level $73.11 $13.91
Resistance Level $84.84 $16.69
Average True Range (ATR) 2.96 0.83
MACD 0.02 0.15
Stochastic Oscillator 59.06 33.38

Price Performance

Historical Comparison
LNTH
STVN

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: